Gilead Sciences announces agreement with Tibotec Pharmaceuticals
28 June 2011 | By Gilead Sciences, Inc.
Development and commercialization of a new fixed-dose antiretroviral combination product...
List view / Grid view
28 June 2011 | By Gilead Sciences, Inc.
Development and commercialization of a new fixed-dose antiretroviral combination product...
13 June 2011 | By Gilead Sciences, Inc.
Gilead Sciences, Inc. is pleased to announce that Kevin Young, has been appointed a Commander of The British Empire...
5 May 2011 | By Gilead Sciences, Inc.
Gilead Sciences, Inc. has extended its funding support of the Gilead Sciences Research Centre at the Institute of Organic Chemistry and Biochemistry (IOCB) in Prague...
20 April 2011 | By Gilead Sciences
Gilead & MicroDose Therapeutx have entered into an exclusive worldwide license...
22 February 2011 | By Gilead Sciences
Gilead Sciences, Inc. & Calistoga Pharmaceuticals, Inc., announced the signing of a definitive agreement pursuant to which Gilead will acquire Calistoga for $375 million...